1.
J Glob Infect Dis
; 15(1): 40, 2023.
Article
in English
| MEDLINE | ID: covidwho-2260282
2.
Am J Trop Med Hyg
; 103(5): 2150, 2020 11.
Article
in English
| MEDLINE | ID: covidwho-918893
Subject(s)
Anti-Infective Agents , Coronavirus Infections , Pandemics , Pneumonia, Viral , Strongyloides stercoralis , Strongyloidiasis , Animals , Betacoronavirus , COVID-19 , Humans , SARS-CoV-2
3.
Am J Trop Med Hyg
; 103(4): 1590-1592, 2020 10.
Article
in English
| MEDLINE | ID: covidwho-914663
ABSTRACT
The SARS-CoV-2 virus has emerged and rapidly evolved into a current global pandemic. Although bacterial and fungal coinfections have been associated with COVID-19, little is known about parasitic infection. We report a case of a COVID-19 patient who developed disseminated strongyloidiasis following treatment with high-dose corticosteroids and tocilizumab. Screening for Strongyloides infection should be pursued in individuals with COVID-19 who originate from endemic regions before initiating immunosuppressive therapy.